CClinicalTrials.gg
Sign In
Status unknownNCT03066284Updated Feb 28, 2017

A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes

An observational study in Type 1 Diabetes Mellitus, sponsored by Dasman Diabetes Institute. Status unknown at 1 site in Kuwait. Open to participants aged 4 Years to 18 Years. Per ClinicalTrials.gov, last updated 2017-02-28.

Sponsored by Dasman Diabetes Institute · Observational

The sponsor has not verified this record recently (last verified Feb 2017), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Other
Enrollment
20
Ages
4 Years to 18 Years
Sex
All
01

Study summary

Using qualitative method; a qualitative case study using semi-structured interviews to explore patients' experiences. Study population of insulin pump patients aged 11-18 years old will be recruited from pediatrics with T1D at Dasman Diabetes Institute; who started using CSII at least one year ago and their parents. Semi-structured interviews will be recorded and then transcribed word by word. Data analysis will be performed using an inductive thematic approach.

Read the detailed description

SPECIFIC AIMS

  1. To explore the experiences of adolescents and their parents and parents ofi children with type 1 diabetes in Kuwait about the use of Insulin Pump Therapy (IPT) in the context of their quality of life.
  2. To gain in-depth understanding of the perceptions of adolescents and their parents and parents of children with type 1 diabetes in Kuwait with T1DM about IPT and its use for diabetes management.

Design A qualitative case study methodology will be adopted using semi-structured interviews for data gathering. Interviews will be conducted with a purposive sample including adolescents and their parents and parents of children with type 1 diabetes in Kuwait with T1D, who are on CSII therapy at least 12 months, along with their parents.

02

Conditions studied

  • Type 1 Diabetes Mellitus

Keywords

  • Children
  • Adolescents
  • Parents
  • Insulin Pump Therapy
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 20 is below the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Dasman Diabetes Institute is the lead sponsor of 30 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

adolescents and their parents and parents of children with type 1 diabetes in Kuwait with T1D, who are on CSII therapy at least 12 months, and were on MDI for at least 12 months before initiation of CSII

Inclusion criteria

  • Diagnosis of T1 D in Kuwait as specified by their Consultant and in line with the Kuwait Clinical Guidelines diagnosis of T1D (2006) criteria
  • Adolescents between the age of 11 and 18 or children between 2 and 10 years old
  • Kuwaiti or expats
  • Duration of CSII (Insulin Pump Therapy) at least 12 months.
  • Prior to starting Insulin Pump Therapy must have been on MDI for a minimum of 12 months
  • Attend the Insulin Pump clinic at DDI

Exclusion criteria

Exclusion Criteria:

  • Non-English \& non-Arabic speakers
  • Presence of a learning disability
  • Diagnosis of any diabetes complication before starting the CSII therapy
  • Diagnosis of psychological problem
05

Study design

Observational model
Case-only
Time perspective
Other
Enrollment
20 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Impact of IPT on QoL of children and adolescents from their perspective and their parents' perspective

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03066284
Lead sponsor
Dasman Diabetes Institute
Responsible party
nehad Taha (Senior Diabetes Educator, Dasman Diabetes Institute) — Principal investigator
First posted
Feb 28, 2017
Start date
Mar 14, 2016
Primary completion
Mar 13, 2017 (estimated)
Completion
Mar 13, 2019 (estimated)
Last update
Feb 28, 2017

Study contacts

Nehad A. Taha, MSc.
Contact
nehad.taha@dasmaninstitute.org
+965-22242999 ext. 2202
Zahra N. Rahme, MSc
Contact
zahraa.rahme@dasmaninstitute.org
+965-22242999 ext. 2207
Nehad A. Taha, MSc.
principal investigator · Dasman Diabetes Institute
Naglaa I. Mesbah, MSc.
principal investigator · Dasman Diabetes Institute
Zahra N. Rahme, MSc.
principal investigator · Dasman Diabetes Institute

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Diabetes Mellitus→

Other studies from this sponsor

Dasman Diabetes Institute

Start the discussion